The effect of liposomal bupivacaine injection during total hip arthroplasty: a controlled cohort study

Benjamin G Domb, Asheesh Gupta, Jon E Hammarstedt, Christine E Stake, Kinzie Sharp, John M Redmond, Benjamin G Domb, Asheesh Gupta, Jon E Hammarstedt, Christine E Stake, Kinzie Sharp, John M Redmond

Abstract

Background: Multimodal analgesia following total hip arthroplasty has been shown to improve patient satisfaction, participation with physical therapy, and allow early return to self care. Liposomal bupivacaine is a formulation of local anesthetic which has the potential to provide anesthesia for up to 72 hours following administration. The purpose of this study was to compare the effectiveness of liposomal bupivacaine with bupivacaine following total hip arthroplasty.

Methods: A retrospective chart review was performed on 28 patients undergoing total hip arthroplasty or hip resurfacing who received intraoperative administration of liposomal bupivacaine. A control group of 30 patients who had previously undergone total hip arthroplasty or hip resurfacing and had received intraoperative administration of bupivacaine also underwent a chart review. Length of stay, post-operative opioid use, and pain scores were compared for both groups.

Results: The average length of stay in the study group was 1.93 days and the control group length of stay was 2.47 days (p ≤ 0.05). Morphine equivalent use was less in the study group during the first 24 hours compared to the control group (p ≤0.05). During the second and third 24 hours the morphine equivalent use difference was not statistically significant. Visual analogue scores were not significantly different between groups at any time point.

Conclusion: Liposomal bupivacaine administration during total hip arthroplasty appears to decrease the need for opioid use post operatively and decrease length of stay. The results of this study justify the need for a well-designed randomized controlled trial utilizing liposomal bupivacaine as part of multimodal analgesia during THA.

Figures

Figure 1
Figure 1
Morphine equivalent use in milligrams during the first 24 hour period, the second 24 hour period and third 24 hour period following surgery for the study and control groups.
Figure 2
Figure 2
VAS average during the first 24 hour period, the second 24 hour period and third 24 hour period following surgery for the study and control groups.

References

    1. Pagnano MW, Hebl J, Horlocker T. Assuring a painless total hip arthroplasty: a multimodal approach emphasizing peripheral nerve blocks. J Arthroplasty. 2006;21(4 Suppl 1):80–84. doi: 10.1016/j.arth.2006.03.001.
    1. Marino J, Russo J, Kenny M, Herenstein R, Livote E, Chelly JE. Continuous lumbar plexus block for postoperative pain control after total hip arthroplasty. A randomized controlled trial. J Bone Joint Surg Am. 2009;91(1):29–37. doi: 10.2106/JBJS.H.00079.
    1. Mathiesen O, Jacobsen LS, Holm HE, Randall S, Adamiec-Malmstroem L, Graungaard BK, Holst PE, Hilsted KL, Dahl JB. Pregabalin and dexamethasone for postoperative pain control: a randomized controlled study in hip arthroplasty. Br J Anaesth. 2008;101(4):535–541. doi: 10.1093/bja/aen215.
    1. Andersen KV, Pfeiffer-Jensen M, Haraldsted V, Soballe K. Reduced hospital stay and narcotic consumption, and improved mobilization with local and intraarticular infiltration after hip arthroplasty: a randomized clinical trial of an intraarticular technique versus epidural infusion in 80 patients. Acta Orthop. 2007;78(2):180–186. doi: 10.1080/17453670710013654.
    1. Andersen LJ, Poulsen T, Krogh B, Nielsen T. Postoperative analgesia in total hip arthroplasty: a randomized double-blinded, placebo-controlled study on peroperative and postoperative ropivacaine, ketorolac, and adrenaline wound infiltration. Acta Orthop. 2007;78(2):187–192. doi: 10.1080/17453670710013663.
    1. Munin MC, Rudy TE, Glynn NW, Crossett LS, Rubash HE. Early inpatient rehabilitation after elective hip and knee arthroplasty. JAMA. 1998;279(11):847–852. doi: 10.1001/jama.279.11.847.
    1. Singelyn FJ, Gouverneur JM. Postoperative analgesia after total hip arthroplasty: i.v. PCA with morphine, patient-controlled epidural analgesia, or continuous “3-in-1” block?: a prospective evaluation by our acute pain service in more than 1,300 patients. J Clin Anesth. 1999;11(7):550–554. doi: 10.1016/S0952-8180(99)00092-6.
    1. Biboulet P, Morau D, Aubas P, Bringuier-Branchereau S, Capdevila X. Postoperative analgesia after total-hip arthroplasty: comparison of intravenous patient-controlled analgesia with morphine and single injection of femoral nerve or psoas compartment block. A prospective, randomized, double-blind study. Reg Anesth Pain Med. 2004;29(2):102–109.
    1. Solovyova O, Lewis CG, Abrams JH, Grady-Benson J, Joyce ME, Schutzer SF, Arumugam S, Caminiti S, Sinha SK. Local infiltration analgesia followed by continuous infusion of local anesthetic solution for total hip arthroplasty: a prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 2013;95(21):1935–1941. doi: 10.2106/JBJS.L.00477.
    1. Andersen LO, Otte KS, Husted H, Gaarn-Larsen L, Kristensen B, Kehlet H. High-volume infiltration analgesia in bilateral hip arthroplasty. A randomized, double-blind placebo-controlled trial. Acta Orthop. 2011;82(4):423–426. doi: 10.3109/17453674.2011.596063.
    1. Stewart DJ, Lambert EW, Stack KM, Pellegrini J, Unger DV, Hood RJ. The effect of intra-articular methadone on postoperative pain following anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2005;87(1):140–144. doi: 10.2106/JBJS.D.01912.
    1. Specht K, Leonhardt JS, Revald P, Mandoe H, Andresen EB, Brodersen J, Kreiner S, Kjaersgaard-Andersen P. No evidence of a clinically important effect of adding local infusion analgesia administrated through a catheter in pain treatment after total hip arthroplasty. Acta Orthop. 2011;82(3):315–320. doi: 10.3109/17453674.2011.570671.
    1. Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19(5):530–536. doi: 10.1016/j.knee.2011.12.004.
    1. Vogel JD. Liposome bupivacaine (EXPAREL(R)) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE phase IV health economics trial. J Pain Res. 2013;6:605–610.
    1. Marcet JE, Nfonsam VN, Larach S. An extended paIn relief trial utilizing the infiltration of a long-acting multivesicular liPosome foRmulation of bupiVacaine, EXPAREL (IMPROVE): a phase IV health economic trial in adult patients undergoing ileostomy reversal. J Pain Res. 2013;6:549–555. doi: 10.2147/JPR.S46467.
    1. Cohen SM. Extended pain relief trial utilizing infiltration of exparel((R)), a long-acting multivesicular liposome formulation of bupivacaine: a phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res. 2012;5:567–572. doi: 10.2147/JPR.S38621.
    1. Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54(12):1552–1559. doi: 10.1097/DCR.0b013e318232d4c1.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다